相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Protein Biomarkers and Risk of Atrial Fibrillation The FHS
Laila Staerk et al.
CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY (2020)
Cardiac natriuretic peptides
Jens P. Goetze et al.
NATURE REVIEWS CARDIOLOGY (2020)
Inflammation and Circulating Natriuretic Peptide Levels
Hannah Fish-Trotter et al.
CIRCULATION-HEART FAILURE (2020)
Reduced left atrial cardiomyocyte PITX2 and elevated circulating BMP10 predict atrial fibrillation after ablation
Jasmeet S. Reyat et al.
JCI INSIGHT (2020)
Data-driven discovery and validation of circulating blood-based biomarkers associated with prevalent atrial fibrillation
Winnie Chua et al.
EUROPEAN HEART JOURNAL (2019)
Specificity of B-Type Natriuretic Peptide Assays: Cross-Reactivity with Different BNP, NT-proBNP, and proBNP Peptides
Amy K. Saenger et al.
CLINICAL CHEMISTRY (2017)
Unraveling the Molecular Complexity of O-Glycosylated Endogenous (N-Terminal) pro-B-Type Natriuretic Peptide Forms in Blood Plasma of Patients with Severe Heart Failure
Bernhard Halfinger et al.
CLINICAL CHEMISTRY (2017)
Clinical Applications of Biomarkers in Atrial Fibrillation
Kay-Won Chang et al.
AMERICAN JOURNAL OF MEDICINE (2017)
Angiopoietin-2: a multifaceted cytokine that functions in both angiogenesis and inflammation
Alexander Scholz et al.
ANNALS REPORTS, VOL 1347 (2015)
Influence of Glycosylation on Diagnostic and Prognostic Accuracy of N-Terminal Pro-B-Type Natriuretic Peptide in Acute Dyspnea: Data from the Akershus Cardiac Examination 2 Study
Helge Rosjo et al.
CLINICAL CHEMISTRY (2015)
Growth Differentiation Factor 15, a Marker of Oxidative Stress and Inflammation, for Risk Assessment in Patients With Atrial Fibrillation Insights From the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial
Lars Wallentin et al.
CIRCULATION (2014)
Worldwide Epidemiology of Atrial Fibrillation A Global Burden of Disease 2010 Study
Sumeet S. Chugh et al.
CIRCULATION (2014)
Thromboembolic event rate in paroxysmal and persistent atrial fibrillation: Data from the GISSI-AF trial
Marcello Disertori et al.
BMC CARDIOVASCULAR DISORDERS (2013)
Circulating cardiovascular biomarkers in recurrent atrial fibrillation: data from the GISSI-Atrial Fibrillation Trial
R. Latini et al.
JOURNAL OF INTERNAL MEDICINE (2011)
Predicting atrial fibrillation recurrence with circulating inflammatory markers in patients in sinus rhythm at high risk for atrial fibrillation: data from the GISSI atrial fibrillation trial
Serge Masson et al.
HEART (2010)
Valsartan for Prevention of Recurrent Atrial Fibrillation
Marcello Disertori et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Cross-reactivity of BNP, NT-proBNP, and proBNP in commercial BNP and NT-proBNP assays: Preliminary observations from the IFCC committee for standardization of markers of cardiac damage
Kristin N. Luckenbill et al.
CLINICAL CHEMISTRY (2008)
Prognostic value of very low plasma concentrations of troponin T in patients with stable chronic heart failure
Roberto Latini et al.
CIRCULATION (2007)
Rationale and design of the GISSI-Atrial Fibrillation trial: a randomized, prospective, multicentre study on the use of valsartan, an angiotensin II AT1-receptor blocker, in the prevention of atrial fibrillation recurrence
Marcello Disertori et al.
JOURNAL OF CARDIOVASCULAR MEDICINE (2006)
Increased cardiac BNP expression associated with myocardial ischemia
JP Goetze et al.
FASEB JOURNAL (2003)
分享论文
